Hue Test Research Articles

Comparison of visual function following implantation of Acrysof Natural intraocular lenses with conventional intraocular lenses

Recently an intraocular lens (IOL) has been introduced which blocks blue light. As blocking blue light may be to the patient's detriment, this study was designed to evaluate visual function following implantation of a blue-blocking (Acrysof Natural) IOL. Patients were recruited for this non-randomized controlled interventional study, from those attending a private rural ophthalmology clinic for cataract surgery (n = 93). Only those who had previously had a conventional IOL implanted into one eye were offered an Acrysof Natural IOL for the second eye. Postoperatively patients underwent refracted Snellen visual acuity, contrast sensitivity using a CSV-1000E instrument and colour vision testing using a Farnsworth D-15 test, with a subset (n = 20) undergoing a Farnsworth-Munsell 100-Hue test. Results were then compared between eyes. Finally, a subset (n = 63) completed a survey designed to assess the subjective impact of the Acrysof Natural IOL. There were no statistically significant differences between eyes implanted with conventional IOLs compared with Acrysof Natural IOLs for visual acuity (t = 0.57; P = 0.57), contrast sensitivity (t = 0.43; P = 0.67 for 3 cycles per degree [cpd], t = 0.56; P = 0.58 for 6 cpd, t = 0.09; P = 0.93 for 12 cpd and t = 0.16; P = 0.87 for 18 cpd) or colour vision with the Farnsworth D-15 (Chi(2) = 0.38; P = 0.55) or the Farnsworth-Munsell 100-Hue test t = 0.34; P = 0.74). Most subjects reported that they could not tell a difference between the two IOLs subjectively or that any difference experienced was not significant. Our sample did not show any significant differences between eyes implanted with conventional IOLs and the Acrysof Natural IOL. We would suggest that the Acrysof Natural IOL may be used without any significant difference in visual function.

A New Color Vision Test to Differentiate Congenital and Acquired Color Vision Defects

To investigate the efficacy of a novel computer-controlled color test for the differentiation of congenital and acquired color vision deficiency. Observational cross-sectional study. Thirty-one patients with congenital color vision deficiency and 134 patients with acquired color vision deficiency with a Snellen visual acuity better than 20/30 underwent an ophthalmologic examination including the Ishihara color test, Hardy-Rand-Rittler test, Nagel anomaloscopy, and the Seohan computerized hue test between June, 2003, and January, 2004. To investigate the type of color vision defect, a graph of the Seohan computerized hue test was divided into 4 quadrants and error scores in each quadrant were summated. The ratio between the sums of error scores of quadrants I and III (Q1+Q3) and those of quadrants II and IV (Q2+Q4) was calculated. Error scores and ratio in quadrant analysis of the Seohan computerized hue test. The Seohan computerized hue test showed that the sum of Q2+Q4 was significantly higher than the sum of Q1+Q3 in congenital color vision deficiency (P<0.01, paired t test) and that the sum of Q2+Q4 was significantly lower than the sum of Q1+Q3 in acquired color vision deficiency (P<0.01, paired t test). In terms of discriminating congenital and acquired color vision deficiency, the ratio in quadrant analysis had 93.3% sensitivity and 98.5% specificity with a reference value of 1.5 by the Seohan computerized hue test (95% confidence interval). The quadrant analysis and ratio of (Q2+Q4)/(Q1+Q3) using the Seohan computerized hue test effectively differentiated congenital and acquired color vision deficiency.

Changes in Colour Discrimination during the Menstrual Cycle

A group of normal women of reproductive age were recruited to investigate colour discrimination during the various phases of the menstrual cycle. Colour vision was tested with the Farnsworth-Munsell 100-hue arrangement test, and the test was administered at 3 time points: the beginning of the cycle, ovulation, and the end of the cycle. We found that colour discrimination was better at ovulation than at the other 2 time points. It is possible that psychological as well as hormonal factors could contribute to improved colour vision performance at ovulation.

Introducing a New Computer-based Test for the Clinical Evaluation of Color Discrimination

To evaluate the Portal color sort test (PCST), a new computer-based test of color vision, by comparing it with a series of clinical tests of color vision in normal and color deficient subjects. Prospective clinical laboratory study. Fifty-nine subjects with normal trichromatic vision or with congenital color vision defects underwent a series of color vision tests that included the 15-plate Ishihara test, the D-15 Farnsworth-Munsell test (D-15), the Farnsworth-Munsell 100-Hue test (FM 100-Hue), and the PCST under rigorous standardized conditions, as recommended by the respective manufacturers. The PCST generates a numerical discrimination score comparable to the FM 100-Hue. To test validity, discrimination scores generated by the PCST were compared with scores on the FM 100-Hue. The Spearman rank correlation between discrimination scores on the FM 100-Hue and the PCST was 0.8 (P < .001). Reliability was assessed by asking patients to retake the PCST at a later sitting. Patients retaking the PCST achieved similar scores on their second sitting as on the first. The correlation in the score between the two tests was 0.7 (95% confidence interval [CI]: 0.4-0.9, P < .001). Median (quartiles) time to complete the PCST was 3.1 minutes. This was faster than the FM 100-Hue time (P < .001), but slower than both the Ishihara and the D-15 (both P < .001). This study suggests that the PCST, a test of color vision deficiency, can be used effectively and reliably as a tool for screening (comparable to the Ishihara plates and the D-15) and grading (comparable to the FM 100-Hue) color discrimination ability.

End‐box scoring artefact evaluation of the Farnsworth‐Munsell 100‐Hue colour vision test

The scoring artefact in the Farnsworth-Munsell 100-Hue test, arising from the grouping of the caps into four boxes, was investigated. The traditional method of scoring performed with the numbers of the anchor caps disregarded and the alternative scoring performed with the numbers of the anchor caps employed, were compared. For the traditional method of scoring, we revealed an increase of the error score of the outside (end-box) caps when the total error score was above 240. On the contrary for scoring performed with the numbers of the anchor caps employed, the difference between the error score of the outside caps and the average error per cap is not significant. To mitigate the end-box artefact and to improve the reliability of the Farnsworth-Munsell 100-Hue test, corrections to the traditional method of scoring are proposed.

Contrast Sensitivity and Color Vision in HIV-infected Individuals Without Infectious Retinopathy

To investigate the relationship between abnormal contrast sensitivity and abnormal color vision among human immunodeficiency virus (HIV)-infected individuals who have normal visual acuity and to seek host factors that predict these abnormalities. Noninterventional, cross-sectional study. We evaluated 71 HIV-infected subjects with visual acuity of 20/25 or better, clear media, and no vision-threatening retinal lesions. Visual function was determined using the Pelli-Robson contrast sensitivity test and the Farnsworth-Munsell 100-Hue color test (FM-100). Results were compared with published values for normal populations and to measures of HIV disease severity. We evaluated two levels of impairment for each visual function. "Mild dysfunction" was defined as > or =1 standard deviation (SD), but <2 SD from normal means. "Abnormal" was defined as > or =2 SD from normal means. The prevalences of abnormal contrast sensitivity and abnormal color vision were 7.0% and 9.9%, respectively. We did not identify relationships between impaired contrast sensitivity and impaired color vision. Impaired color vision was associated with increasing age (r = 0.36, P = .002). We could not identify significant correlations between either contrast sensitivity or color vision values and the following factors: current or nadir (lowest previous) CD4+ T-lymphocyte count, HIV blood level, and Karnofsky score. Abnormal contrast sensitivity and abnormal color vision can occur independently in HIV-infected individuals and can be present in the absence of severe immunosuppression.

Farnsworth and Kinnear method of plotting the Farnsworth Munsell 100-Hue test scores: a comparison

We have compared two different methods of plotting the Farnsworth Munsell FM-100 test, namely the Farnsworth and the Kinnear techniques. Data from 30 individuals having a red-green deficiency were plotted using both techniques. The cap score distributions were analysed using both the Knobaluch Sine wave (Fourier) and the the Red-Green and Blue-Yellow partial scoring methods. We found that the Farnsworth and Kinnear plots give different results for the measures obtained by the Knoblauch method of analysis. On the other hand, the ‘difference score’ obtained from the King-Smith et al. method were not significantly different for the two plotting methods.

Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine

Visual dysfunction has been reported in patients diagnosed with epilepsy. Some of these visual disturbances may be attributable to either the disease process, or the anticonvulsant therapy prescribed to control the seizures. The aims of our study were to evaluate whether color vision and macular function are impaired in epileptic adolescents, to study if the monotherapy with valproic acid (VPA) and carbamazepine (CBZ) can affect color vision and macular function and to determine the possible relationship between color vision, retinal function and antiepileptic drugs (AEDs) dosage and their serum concentrations. We examined 45 (16 male and 29 female, mean age +/- SD, 15.71 +/- 2.01 years) Caucasian epileptic patients suffering from various types of cryptogenic epilepsy before the beginning of therapy and after 1 year of VPA or CBZ monotherapy and 40 sex- and age-matched healthy controls. Color vision was assessed by Farnsworth Munsell (FM) 100-hue test and total error score (TES) was evaluated. This test consists of colored caps: the testee has to arrange the caps according to their colors macular function was assessed by nyctometry evaluating initial recovery time (IRT) and summation method (SM). This test evaluates visual acuity after a period of intense illumination of macula. Analysis of variance was used to evaluate the difference between controls and patients; moreover, Pearson's correlation test have been performed. Before the beginning of therapy, there were no differences in color vision and macular function between controls and epileptic patients. After 1 year, the patients, treated with VPA or CBZ, showed a deficit in FM 100-hue test. At nyctometry, all patients showed no significant variation of macular function between baseline evaluation and second evaluation at end of the follow-up. Our study demonstrates that, in our group of epileptic patients, epilepsy per se does not affect color vision and retinal function. In contrast, after 1 years of therapy with VPA and CBZ these patients showed a deficit in FM 100-hue test although nyctometry evaluation continued to be normal allowing to exclude an impairment in macular function. Further investigations are required to determine the pathophysiological alteration(s) that are at the basis of color perception defects.

Absence of binocular summation, eye dominance, and learning effects in color discrimination

We evaluated binocular summation, eye dominance, and learning in the Trivector and Ellipses procedures of the Cambridge Colour Test (CCT). Subjects (n = 36, 18-30 years old) were recruited among students and staff from the University of São Paulo. Inclusion criteria were absence of ophthalmological complaints and best-corrected Snellen VA 20/20 or better. The subjects were tested in three randomly selected eye conditions: binocular, monocular dominant eye, and nondominant eye. Results obtained in the binocular and monocular conditions did not differ statistically for thresholds measured along the protan, deutan, and tritan confusion axes (ANOVA, P > 0.05). No statistical difference was detected among discrimination ellipses obtained in binocular or monocular conditions (ANOVA, P > 0.05), suggesting absence of binocular summation or of an effect of eye dominance. Possible effects of learning were examined by comparing successive thresholds obtained in the three testing conditions. There was no evidence of improvement as a function of testing order (ANCOVA, P > 0.05). We conclude that CCT thresholds are not affected by binocularity, eye dominance, or learning. Our results differ from those found by Verriest et al. (1982) using the Farnsworth-Munsell 100 Hue test and Hovis et al. (2004) using the Farnsworth-Munsell panel D-15 test.

Colour perception in ADHD

Attention-deficit/hyperactivity disorder (ADHD) is associated with unexplained impairments on speeded naming of coloured stimuli. These deficits may reflect hypofunctioning retinal dopaminergic mechanisms impairing particularly blue-yellow colour discrimination. Colour perception and rapid colour naming ability were investigated in 14 children with ADHD and 13 healthy peers matched for age, gender, and IQ, using the Farnsworth-Munsell 100 Hue Test (FMT) and the Stroop-Colour-Word test. Children with ADHD committed more errors on the FMT, particularly on discrimination of colours along the blue-yellow axis, and were slower on Stroop subtests involving colour naming. However, the latter deficit was accounted for similarly by blue-yellow and red-green discrimination abilities. Blue-yellow colour perception problems in ADHD contribute to but do not fully explain the observed slowed colour naming.

Transcaruncular Orbital Decompression: An Alternate Procedure for Graves Ophthalmopathy With Compressive Optic Neuropathy

To study the efficacy of transcaruncular orbital apex decompression for Graves ophthalmopathy with compressive optic neuropathy nonresponsive to pulse corticosteroids. Retrospective, interventional case series study. From August 1999 to November 2003, transcaruncular orbital decompression was performed in 22 consecutive Graves ophthalmopathy patients with compressive optic neuropathy refractory to pulse corticosteroids. The average period of corticosteroid treatment was 16.1 +/- 5.2 days. Main outcome measures were preoperative and postoperative best-corrected vision, Hertel exophthalmometry, 100-hue color sensation test, visual evoked potential, visual field, and new-onset diplopia. Visual acuity improved significantly from 1.08 +/- 0.24 logarithm of minimal angle of resolution (logMAR) preoperatively to 0.29 +/- 0.18 logMAR postoperatively (P < .0001). Average improvement in retinal sensitivity was 9.4 +/- 8.2 dB, in P(100) value of visual evoked potential was 27.5 +/- 20.1, and in "total errors" of the 100-hue test was 309.9 +/- 214.3 after surgery. Average retroplacement effect was 3.7 +/- 1.6 mm. Statistical analysis showed significant differences between preoperative and postoperative measurements for all above parameters (P < .0001). New-onset diplopia occurred in 38% of patients. There were no complications specifically attributable to the transcaruncular technique. The transcaruncular approach offers access to the medial and inferior wall for orbital apex decompression in Graves ophthalmopathy patients with compressive optic neuropathy refractory to pulse corticosteroids. Advantages over other approaches included no external scar, less damage to adjacent tissue, and wide exposure to the entire medial wall.

Neurosensory effects of chronic exposure to arsenic via drinking water in Inner Mongolia: II. Vibrotactile and visual function

This study was designed to assess the effects of exposure to arsenic in drinking water on visual and vibrotactile function in residents of the Bamen region of Inner Mongolia, China. Arsenic was measured by hydride generation atomic fluorescence. 321 participants were divided into three exposure groups- low (non-detectable-20), medium (100-300) and high (400-700 microg/l) arsenic in drinking water (AsW). Three visual tests were administered: acuity, contrast sensitivity and color discrimination (Lanthony's Desaturated 15 Hue Test). Vibration thresholds were measured with a vibrothesiometer. Vibration thresholds were significantly elevated in the high exposure group compared to other groups. Further analysis using a spline regression model suggested that the threshold for vibratory effects is between 150-170 microg/l AsW. These findings provide the first evidence that chronic exposure to arsenic in drinking water impairs vibrotactile thresholds. The results also indicate that arsenic affects neurological function well below the 1000 microg/I concentration reported by NRC (1999). No evidence of arsenic-related effects on visual function was found.

Color perception with AcrySof Natural and AcrySof single-piece intraocular lenses under photopic and mesopic conditions

To examine color perception in patients receiving bilateral implantation of an ultraviolet (UV) and blue-light filtering intraocular lens (IOL) (AcrySof Natural SN60AT, Alcon Laboratories Inc.) or a UV-only filtering IOL (AcrySof SA60AT) and to compare the results with those in a phakic group. Cincinnati, Ohio, USA. In this prospective study, age-matched subjects who passed the Ishihara test and had visual acuities of 20/25 or better were recruited. There were 2 pseudophakic groups (bilateral SN60AT or SA60AT IOLs) and 1 phakic group. The Farnsworth-Munsell (FM) 100-hue test was administered to each subject twice under different conditions. The phakic and AcrySof Natural SN60AT groups were tested under photopic and mesopic conditions. The SA60AT subjects were further divided into subgroups (with and without yellow clip-on lenses) and tested under photopic and mesopic conditions. A 1-way analysis of variance (ANOVA) of the square-root-transformed total error score showed no statistical differences (P = .637) between the treatment groups. Similarly, a 1-way ANOVA of the red-green error score (P = .729) and blue-yellow error score (P = .484) indicated no statistically significant differences between the treatment groups. The ANOVA results of the FM 100-hue test under mesopic conditions showed that the total error score in the AcrySof Natural IOL group was significantly lower (P = .046) than in the phakic group. There were no between-group differences in error scores under mesopic conditions. The FM 100-hue testing showed no difference in color perception between subjects with AcrySof Natural IOLs and those in an age-matched phakic control group or in those with a UV-only filtering AcrySof IOL with or without yellow clip-on lenses.

Evaluation of cerebral dyschromatopsia using color afterimage

Cerebral dyschromatopsia is traditionally evaluated by color discrimination tests such as the Farnsworth-Maunsell 100 Hue Test. These tests are also used to evaluate color-perception deficits caused by eye disease, and they do not tell us whether color perception is impaired in the eye or in the brain. Here, we used color afterimage to isolate color-perception deficits in the brain from those in the eyes, in a patient with cerebral dyschromatopsia. The results showed that the patient perceived color afterimage of yellow and blue with abnormal duration and chromaticity. On the other hand, the patient performed normally on the Farnsworth-Maunsell 100 Hue Test. We conclude that the color afterimage test would be useful to evaluate color perception in the brain.

Improvement in colour vision parameters following successful trabeculectomy

To determine whether colour vision improves following reduction of intraocular pressure (IOP) in glaucoma patients. The medical records of 29 glaucoma patients (41 eyes) were reviewed. Inclusion criteria required subjects to have made more than four visits to the Glaucoma Service Laboratory and to undergo a thorough eye examination including a Farnsworth-Munsell 100-hue colour vision test and Goldmann tonometry before and after pressure lowering. Colour vision parameters of total error score (TES), yellow-blue score (YBS) and red-green score (RGS) were measured. The study group consisted of 21 eyes of glaucoma patients who underwent uncomplicated trabeculectomy with an IOP reduction of >/= 20% from baseline. The control group consisted of 21 eyes of glaucoma patients matched for age and colour vision, who received medication and/or underwent surgery with a post-intervention IOP reduction of < 20% from baseline. The primary outcome was a comparison of pre- and post-intervention colour vision parameters between the two groups. There was a statistically significant improvement in TES (43 +/- 44, p < 0.001), RGS (19 +/- 27, p = 0.0077) and YBS (23 +/- 29, p = 0.0007) in the study group compared with the control group. The improvement in TES (r = 0.52, p < 0.001), RGS (r = 0.55, p < 0.001) and YBS (r = 0.40, p = 0.008) was correlated with the percentage of IOP reduction. There was no statistically significant difference between improvement in Y-B and R-G scores in the study group. Intraocular pressure reduction of >/= 20% post-trabeculectomy was associated with an improvement in colour vision. Colour vision tests may be useful as an adjunctive outcome measure for therapeutic interventions.

Colour vision and retinal nerve fibre layer photography in patients with an Acrysof® Natural intraocular lens

To study colour vision and retinal nerve fibre layer (RNFL) photographs in patients with an Acrysof Natural intraocular lens (IOL). We carried out a randomized double-blind study. An Acrysof Natural IOL (model SN60AT) was implanted in 25 eyes of 19 patients and an Acrysof IOL (model SA60AT) was implanted in 27 eyes of 18 control patients. The patients returned for colour vision tests and fundus photography 1-6 months after the surgery. Standard pseudoisochromatic plates, part 2, were correctly interpreted and the Farnsworth-Munsell 100-hue test (FM 100) total and individual box scores were normal in all IOL eyes. In the FM 100 hue test there were no significant differences in the results of the total error scores or the error scores of the individual boxes between the eyes with Acrysof Natural and those with Acrysof lenses. The yellow coloration of the Acrysof Natural IOL did not affect the visibility of the RNFL in photographs. The Acrysof Natural IOL did not affect colour vision in the tested patients, even in the blue region of the spectrum, and can be implanted in patients who need to have normal colour vision for the purposes of their occupation. The Acrysof Natural IOL does not interfere with RNFL photography and can also be used in patients with glaucoma.

Color vision and contrast sensitivity in epilepsy patients treated with initial tiagabine monotherapy

The purpose of the study was to determine whether the use of a GABAergic antiepileptic drug (AED), tiagabine, affects color vision and contrast sensitivity. Twenty newly diagnosed patients with partial epilepsy (aged 19–72 years), receiving tiagabine as their initial monotherapy for 5–41 months were examined. Color vision was examined with the Standard Pseudoisochromatic Plates 2 (SPP2), with the Farnsworth–Munsell 100 Hue Test (FM100) and with the Color Vision Meter 712 (CVM) anomaloscope. Contrast sensitivity was measured with the Pelli–Robson letter chart. Three patients excluded from the color vision evaluation for congenital red-green color vision defects. Seven out of 17 patients (41%) had acquired color vision deficit examined with the FM100. The CVM anomaloscope revealed minor defects in two patients. Contrast sensitivity function was within normal ranges. The present study suggests that AED therapy with tiagabine, like with other established and newer AEDs may interfere with color perception.

Evaluation of the New Web-Based “Colour Assessment and Diagnosis” Test

The purpose of the study was to determine the sensitivity, specificity, and repeatability of the web-based Colour Assessment and Diagnosis (CAD) test in comparison to current tests of color vision. Thirty color normals and 30 color deficients, identified and diagnosed by the Nagel anomaloscope, were tested. The results of the CAD test were compared with standard tests like Nagel anomaloscope, Ishihara (concise version, 2001), Hardy, Rand and Rittler (HRR; 4 ed) pseudoisochromatic test, and the Farnsworth Munsell 100 (FM-100) hue test. Using the Nagel anomaloscope as the "gold standard," the sensitivity with the CAD test was 93.33%, Ishihara 96%, HRR 100%, and the FM-100 hue 100%. The specificity was 100% with CAD and the Ishihara color plates, whereas it was 33% with the HRR and 83% with the FM-100 hue test. The concurrent validity of the CAD test for color normals was 93.75%. The concurrent validity of CAD test for color deficiency was 100%. Thus, anyone failing the CAD test has a color defect. The coefficient of agreement for the Nagel anomaloscope and the CAD test was 0.93, with Ishihara it was 0.96, with the HRR it was 0.33, and with FM-100 hue it was 0.83. These results showed that the CAD test is a valid test for identifying congenital red-green color deficiency. Further testing is required in a larger population of anomalous trichromats.

Visual function in epilepsy patients treated with initial valproate monotherapy

To investigate whether initial valproate (VPA) monotherapy for the treatment of epilepsy causes visual field defects and visual dysfunction. In a cross-sectional study, visual fields were examined with the kinetic Goldmann and automated Humphrey perimeters, contrast sensitivity function with the Pelli-Robson letter chart and colour vision with the Standard Pseudoisochromatic Plates Part 2 (SPP 2) and Farnsworth-Munsell 100 Hue test (FM 100) in eighteen epilepsy patients (aged 18--50 years, 30.2.+/-10 years, mean+/-S.D.) treated with initial valproate monotherapy for 2--20 years (8.4+/-5.1 years). None had vigabatrin-type, concentric visual field defect with the kinetic Goldmann or automated Humphrey perimetries. In the Humphrey perimetry, the mean deviation for the group was within normal limits varying from -2.53 to 0.59 dB (-0.74+/-0.80 dB) in the right eye and from -2.66 to 0.67 dB (-0.78+/-0.82 dB) in the left eye. In the FM 100 test, acquired colour vision deficiency was found in two out of 18 patients (11%, 95% CI: 0--25%). However, the mean total error score was lower in the patient group than in the control group. All patients had normal contrast sensitivity function. The use of VPA in the treatment of epilepsy is not associated with visual field defects similar to vigabatrin, but may induce abnormalities in colour vision.

Colour Vision in Migraine: Selective Deficits for S-Cone Discriminations

Three studies are reported that explore colour perception in migraine. In each, sensitivity for colours detected selectively by the S-cones and the L- and M-cones was assessed separately. The first study assessed the discrimination of small colour differences using the Farnsworth-Munsell 100-hue test. The second assessed threshold detection for purple, yellow, red and green targets on five equiluminant background colours. The third examined supra-threshold colour scaling using two colour series, purple-yellow and red-green. Each study indicated that differences in colour perception between migraine and control groups were restricted to colours detected by the S-cones, there were no differences in performance for colours detected by the L- and M-cones. The results are discussed in terms of possible pathologies in the early visual pathways.